Related Experiment Video
Updated: Aug 14, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Predictive Factors of Stent Patency in Iliofemoral Venous Diseases in a Multicentre Cohort Study
Olivier Espitia1, Frédéric Douane2, Jeanne Hersant3
1Nantes Université, CHU Nantes, Department of Internal and Vascular Medicine, Nantes, France.
Insights
Patients with non-thrombotic iliac vein lesions (NIVL) show superior primary stent patency after venous stenting compared to those with acute deep vein thrombosis (aDVT) or post-thrombotic syndrome (PTS). Long-term anticoagulation prior to stenting was linked to worse outcomes in the aDVT group.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Thrombosis Research
Background:
- Lower limb (LL) deep vein thrombosis can necessitate venous stenting.
- Predictive factors for stent patency in different patient groups remain crucial for optimizing outcomes.
Purpose of the Study:
- To assess primary stent patency predictive factors in patients undergoing LL venous stenting.
- To compare outcomes among patients with non-thrombotic iliac vein lesions (NIVL), acute deep vein thrombosis (aDVT), and post-thrombotic syndrome (PTS).
Main Methods:
- Retrospective analysis of 377 patients from seven hospitals (2014-2020) with LL venous stenting.
- Inclusion criteria: history of LL vein thrombosis, iliac or common femoral venous stent, and ≥6-month follow-up with imaging.
- Comparison of anticoagulant and antiplatelet therapy strategies and outcomes across NIVL, aDVT, and PTS groups.
Main Results:
- Primary patency was significantly higher in NIVL (99.3%) versus PTS (68.6%, p < .001) and aDVT (83.6%, p = .002).
- PTS patients required more stents, with more placed below the inguinal ligament (p < .001).
- Long-term anticoagulation before stenting was the sole predictor of worse primary patency in the aDVT group.
Conclusions:
- Non-thrombotic iliac vein lesions are associated with better primary patency after venous stenting compared to venous thrombotic disorders.
- Pre-stenting long-term anticoagulation is identified as a negative predictor for primary patency in acute deep vein thrombosis patients.
Objective:
This study assessed primary stent patency predictive factors in three groups of patients with history of lower limb (LL) vein thrombosis: non-thrombotic iliac vein lesion (NIVL), acute deep vein thrombosis (aDVT), and post-thrombotic syndrome (PTS).
Methods:
Consecutive patients from January 2014 to December 2020 with history of LL vein stenting from seven hospitals were included. All patients received an iliac or common femoral venous stent and had at least a six month follow up available with stent imaging. Anticoagulant and antiplatelet therapy strategies employed after venous stenting are reported and compared between groups.
Results:
This study included 377 patients: 134 NIVL, 55 aDVT, and 188 PTS. Primary patency was statistically significantly higher in the NIVL group (99.3%) compared with the PTS group (68.6%) (p < .001) and the aDVT group (83.6%) (p = .002). PTS patients received a statistically significantly greater number of stents (p < .001) and had more stents below the inguinal ligament (p < .001). Median follow up was 28.8 months (IQR 16, 47). Discontinuation of antiplatelet therapy at the last assessment was 83.6% for NIVL, 100% for aDVT, and 95.7% for the PTS group (p < .001). Discontinuation of anticoagulation therapy at the last assessment was 93.2% for NIVL, 25.0% for aDVT, and 70.3% for the PTS group (p < .001). The only predictor of worse primary patency in the aDVT group was long term anticoagulation before stenting.
Conclusion:
Patients with NIVL have better primary patency after venous stenting than patients with venous thrombotic disorders. Long term anticoagulation before stenting was the only factor associated with poorer primary patency in patients with aDVT.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...